Liver function tests: Difference between revisions

Revision as of 22:18, 30 June 2022

Revision as of 22:19, 30 June 2022

Line 14:

}}

'''Liver function tests''' ('''LFTs''' or '''LFs'''), also referred to as a hepatic panel, are groups of blood tests that provide information about the state of a patient's [[liver]].<ref name="Lee2009">{{cite book|last=Lee|first=Mary|title=Basic Skills in Interpreting Laboratory Data|url=https://books.google.com/books?id=AUSIRcV_as0C&pg=PA259|access-date=5 August 2011|date=2009-03-10|publisher=ASHP|isbn=978-1-58528-180-0|page=259}}</ref> These tests include [[prothrombin time]] (PT/INR), [[activated Partial Thromboplastin Time]] (aPTT), [[albumin]], [[bilirubin]] (direct and indirect), and others. The liver transaminases [[Aspartate transaminase|aspartate transaminase (AST or SGOT)]] and [[Alanine transaminase|alanine transaminase (ALT or SGPT)]] are useful biomarkers of liver injury in a patient with some degree of intact liver function.<ref name="pmid10221307">{{cite journal | author = Johnston DE | title = Special considerations in interpreting liver function tests | journal = Am Fam Physician | volume = 59 | issue = 8 | pages = 2223–30 | year = 1999 | pmid = 10221307 }}</ref><ref name="McClatchey2002">{{cite book|last=McClatchey|first=Kenneth D.|title=Clinical laboratory medicine|url=https://books.google.com/books?id=3PJVLH1NmQAC&pg=PA288|year=2002|publisher=Lippincott Williams & Wilkins|isbn=978-0-683-30751-1|page=288}}</ref><ref name="MengelSchwiebert2005">{{cite book|last1=Mengel|first1=Mark B.|last2=Schwiebert|first2=L. Peter|title=Family medicine: ambulatory care & prevention|url=https://books.google.com/books?id=XvLo7xvmFo0C&pg=PA268|year=2005|publisher=McGraw-Hill Professional|isbn=978-0-07-142322-9|page=268}}</ref> Most [[liver disease]]s cause only mild symptoms initially, but these diseases must be detected early. Hepatic (liver) involvement in some diseases can be of crucial importance. This testing is performed on a patient's blood sample. Some tests are associated with functionality (e.g., albumin), some with cellular integrity (e.g., [[transaminase]]), and some with conditions linked to the biliary tract ([[gamma-glutamyl transferase]] and [[alkaline phosphatase]]). Because some of these tests do not measure function, it is more accurate to call these liver chemistries or liver tests rather than liver function tests.<ref>{{Cite journal|last1=Kwo|first1=Paul Y.|last2=Cohen|first2=Stanley M.|last3=Lim|first3=Joseph K.|date=January 2017|title=ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries|url=https://dx.doi.org/10.1038%2Fajg.2016.517|journal= American Journal of Gastroenterology|language=en-US|volume=112|issue=1|pages=18–35|doi=10.1038/ajg.2016.517|pmid=27995906|s2cid=23788795|issn=0002-9270}}</ref> Several biochemical tests are useful in the evaluation and management of patients with hepatic dysfunction. These tests can be used to detect the presence of liver disease. They can help distinguish among different types of liver disorders, gauge the extent of known liver damage, and monitor the response to treatment. Some or all of these measurements are also carried out (usually about twice a year for routine cases) on those individuals taking certain medications, such as anticonvulsants, to ensure that thethese medications are not adversely impacting the person's liver.{{cn|date=May 2022}}

==Standard liver panel==